Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Targeting Adeno-Associated Virus Vectors for Local Delivery to Fractures and Systemic Delivery to the Skeleton.

Lee LR, Peacock L, Lisowski L, Little DG, Munns CF, Schindeler A.

Mol Ther Methods Clin Dev. 2019 Sep 5;15:101-111. doi: 10.1016/j.omtm.2019.08.010. eCollection 2019 Dec 13.

2.

Pretreatment with Pamidronate Decreases Bone Formation but Increases Callus Bone Volume in a Rat Closed Fracture Model.

Morse A, McDonald MM, Mikulec K, Schindeler A, Munns CF, Little DG.

Calcif Tissue Int. 2019 Oct 1. doi: 10.1007/s00223-019-00615-z. [Epub ahead of print]

PMID:
31578632
3.

FGF23, Hypophosphatemia, and Emerging Treatments.

Imel EA, Biggin A, Schindeler A, Munns CF.

JBMR Plus. 2019 May 13;3(8):e10190. doi: 10.1002/jbm4.10190. eCollection 2019 Aug. Review.

4.

Abnormal Cortical and Trabecular Bone in Youth With Type 1 Diabetes and Celiac Disease.

Pham-Short A, Donaghue KC, Ambler G, Briody J, Garnett S, Munns CF, Craig ME.

Diabetes Care. 2019 Aug;42(8):1489-1495. doi: 10.2337/dc18-2376. Epub 2019 Jun 4.

PMID:
31167891
5.

Safety and effectiveness of stoss therapy in children with vitamin D deficiency.

Tannous P, Fiscaletti M, Wood N, Gunasekera H, Zurynski Y, Biggin A, Kilo T, Hayes E, Munns C.

J Paediatr Child Health. 2019 May 28. doi: 10.1111/jpc.14497. [Epub ahead of print]

PMID:
31136042
6.

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA.

Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. Erratum in: Lancet. 2019 Jul 13;394(10193):120.

PMID:
31104833
7.

A comparison of subtraction MRI with the standard contrast-enhanced imaging in Perthes' disease.

Jamil K, Walker T, Onikul E, Munns CF, Little DG.

J Child Orthop. 2019 Feb 1;13(1):82-88. doi: 10.1302/1863-2548.13.180136.

8.

Long-term Outcomes of Adolescent Anorexia Nervosa on Bone.

Mumford J, Kohn M, Briody J, Miskovic-Wheatley J, Madden S, Clarke S, Biggin A, Schindeler A, Munns C.

J Adolesc Health. 2019 Mar;64(3):305-310. doi: 10.1016/j.jadohealth.2018.07.025. Epub 2018 Dec 11.

PMID:
30819332
9.

Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model.

Lee LR, Peacock L, Ginn SL, Cantrill LC, Cheng TL, Little DG, Munns CF, Schindeler A.

Calcif Tissue Int. 2019 Apr;104(4):426-436. doi: 10.1007/s00223-018-0504-3. Epub 2018 Dec 8.

PMID:
30535573
10.

Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J.

Endocr Rev. 2019 Aug 1;40(4):1109-1151. doi: 10.1210/er.2018-00126.

11.

A novel CASR mutation (p.Glu757Lys) causing autosomal dominant hypocalcaemia type 1

Kwan B, Champion B, Boyages S, Munns CF, Clifton-Bligh R, Luxford C, Crawford B.

Endocrinol Diabetes Metab Case Rep. 2018 Sep 25;2018. pii: EDM180107. doi: 10.1530/EDM-18-0107.

12.

Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.

Offiah AC, Vockley J, Munns CF, Murotsuki J.

Pediatr Radiol. 2019 Jan;49(1):3-22. doi: 10.1007/s00247-018-4239-0. Epub 2018 Oct 3. Review.

13.

MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of Vitamin D.

Ebeling PR, Adler RA, Jones G, Liberman UA, Mazziotti G, Minisola S, Munns CF, Napoli N, Pittas AG, Giustina A, Bilezikian JP, Rizzoli R.

Eur J Endocrinol. 2018 Oct 12;179(5):R239-R259. doi: 10.1530/EJE-18-0151. Review.

PMID:
30131372
14.

Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals.

Chrisp GL, Maguire AM, Quartararo M, Falhammar H, King BR, Munns CF, Torpy DJ, Hameed S, Rushworth RL.

Clin Endocrinol (Oxf). 2018 Nov;89(5):577-585. doi: 10.1111/cen.13826. Epub 2018 Sep 24.

PMID:
30086199
15.

Diagnosis of Recurrent Fracture in a Pediatric Cohort.

Fiscaletti M, Coorey CP, Biggin A, Briody J, Little DG, Schindeler A, Munns CF.

Calcif Tissue Int. 2018 Nov;103(5):529-539. doi: 10.1007/s00223-018-0449-6. Epub 2018 Jun 25.

PMID:
29943187
16.

Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N.

Br J Clin Pharmacol. 2018 Oct;84(10):2194-2207. doi: 10.1111/bcp.13652. Epub 2018 Jul 17. Review.

17.

Protocol for a randomised control trial of bisphosphonate (zoledronic acid) treatment in childhood femoral head avascular necrosis due to Perthes disease.

Jamil K, Zacharin M, Foster B, Donald G, Hassall T, Siafarikas A, Johnson M, Tham E, Whitewood C, Gebski V, Cowell CT, Little DG, Munns CF.

BMJ Paediatr Open. 2017 Sep 14;1(1):e000084. doi: 10.1136/bmjpo-2017-000084. eCollection 2017.

18.

Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.

Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF; APEG Bone Mineral Working Group.

J Paediatr Child Health. 2018 Mar;54(3):223-233. doi: 10.1111/jpc.13768.

PMID:
29504223
19.

The importance of vitamin D in maternal and child health: a global perspective.

Fiscaletti M, Stewart P, Munns CF.

Public Health Rev. 2017 Sep 1;38:19. doi: 10.1186/s40985-017-0066-3. eCollection 2017. Review.

20.

Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.

Fiscaletti M, Biggin A, Bennetts B, Wong K, Briody J, Pacey V, Birman C, Munns CF.

Bone. 2018 May;110:66-75. doi: 10.1016/j.bone.2018.01.031. Epub 2018 Jan 31.

PMID:
29382611
21.

Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.

Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.

Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. Review.

22.

Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.

Biggin A, Munns CF.

Curr Osteoporos Rep. 2017 Oct;15(5):412-418. doi: 10.1007/s11914-017-0401-0. Review.

PMID:
28823022
23.

Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta.

Little DG, Peacock L, Mikulec K, Kneissel M, Kramer I, Cheng TL, Schindeler A, Munns C.

Bone. 2017 Aug;101:96-103. doi: 10.1016/j.bone.2017.04.016. Epub 2017 Apr 29.

PMID:
28461254
24.

Response to the letter by Sugiyama and Oda.

Mughal MZ, Thacher TD, Specker BL, Shaw NJ, Kiely M, Munns CF, Högler W.

J Clin Endocrinol Metab. 2016 Oct;101(10):L97-L98. No abstract available.

PMID:
27702314
25.

Nutritional rickets in immigrant and refugee children.

Thacher TD, Pludowski P, Shaw NJ, Mughal MZ, Munns CF, Högler W.

Public Health Rev. 2016 Jul 22;37:3. doi: 10.1186/s40985-016-0018-3. eCollection 2016. Review.

26.

Central Adrenal Insufficiency Is Not a Common Feature in CHARGE Syndrome: A Cross-Sectional Study in 2 Cohorts.

Wong MT, van Ravenswaaij-Arts CM, Munns CF, Hsu P, Mehr S, Bocca G.

J Pediatr. 2016 Sep;176:150-5. doi: 10.1016/j.jpeds.2016.05.065. Epub 2016 Jun 16.

PMID:
27321065
27.

Transoesophageal echocardiography before DC cardioversion: a survey of clinical practice in the UK.

Ahluwalia N, Bhattacharyya S, Munns C, Chambers J.

Echo Res Pract. 2016 Mar;3(1):1-3. doi: 10.1530/ERP-15-0039. Epub 2016 Jan 19.

28.

Rickets and osteomalacia: a call for action to protect immigrants and ethnic risk groups.

Högler W, Munns CF.

Lancet Glob Health. 2016 Apr;4(4):e229-30. doi: 10.1016/S2214-109X(16)00061-9. No abstract available.

29.

Transformative therapy in hypophosphatasia.

Bishop N, Munns CF, Ozono K.

Arch Dis Child. 2016 Jun;101(6):514-515. doi: 10.1136/archdischild-2015-309579. Epub 2016 Mar 18. No abstract available.

30.

Effects of whole-body vibration training on physical function, bone and muscle mass in adolescents and young adults with cerebral palsy.

Gusso S, Munns CF, Colle P, Derraik JG, Biggs JB, Cutfield WS, Hofman PL.

Sci Rep. 2016 Mar 3;6:22518. doi: 10.1038/srep22518.

31.

Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age.

Rushworth RL, Falhammar H, Munns CF, Maguire AM, Torpy DJ.

Int J Endocrinol. 2016;2016:5748264. doi: 10.1155/2016/5748264. Epub 2016 Jan 6.

32.

Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence.

Jefferson A, Leonard H, Siafarikas A, Woodhead H, Fyfe S, Ward LM, Munns C, Motil K, Tarquinio D, Shapiro JR, Brismar T, Ben-Zeev B, Bisgaard AM, Coppola G, Ellaway C, Freilinger M, Geerts S, Humphreys P, Jones M, Lane J, Larsson G, Lotan M, Percy A, Pineda M, Skinner S, Syhler B, Thompson S, Weiss B, Witt Engerström I, Downs J.

PLoS One. 2016 Feb 5;11(2):e0146824. doi: 10.1371/journal.pone.0146824. eCollection 2016.

33.

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).

Padhye B, Dalla-Pozza L, Little D, Munns C.

Cancer Med. 2016 May;5(5):960-7. doi: 10.1002/cam4.645. Epub 2016 Jan 20.

34.

Global Consensus Recommendations on Prevention and Management of Nutritional Rickets.

Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P, Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W.

J Clin Endocrinol Metab. 2016 Feb;101(2):394-415. doi: 10.1210/jc.2015-2175. Epub 2016 Jan 8. Review.

35.

Global Consensus Recommendations on Prevention and Management of Nutritional Rickets.

Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P, Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W.

Horm Res Paediatr. 2016;85(2):83-106. doi: 10.1159/000443136. Epub 2016 Jan 8.

36.

The Immune Phenotype of Patients with CHARGE Syndrome.

Hsu P, Ma A, Barnes EH, Wilson M, Hoefsloot LH, Rinne T, Munns C, Williams G, Wong M, Mehr S.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):96-103.e2. doi: 10.1016/j.jaip.2015.09.004. Epub 2015 Nov 7.

PMID:
26563674
37.

Erratum. Vitamin D supplementation and the effects on glucose metabolism during pregnancy: a randomized controlled trial. Diabetes Care 2014;37:1837-1844.

Yap C, Cheung NW, Gunton JE, Athayde N, Munns CF, Duke A, McLean M.

Diabetes Care. 2015 Oct;38(10):1992. doi: 10.2337/dc15-er10. No abstract available.

PMID:
26404929
38.

A Practical Approach to Children with Recurrent Fractures.

Korula S, Titmuss AT, Biggin A, Munns CF.

Endocr Dev. 2015;28:210-25. doi: 10.1159/000381047. Epub 2015 Jun 12. Review.

PMID:
26138844
39.

Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.

Munns CF, Fahiminiya S, Poudel N, Munteanu MC, Majewski J, Sillence DO, Metcalf JP, Biggin A, Glorieux F, Fassier F, Rauch F, Hinsdale ME.

Am J Hum Genet. 2015 Jun 4;96(6):971-8. doi: 10.1016/j.ajhg.2015.04.017. Epub 2015 May 28.

40.

Cystic fibrosis-related bone disease in children: Examination of peripheral quantitative computed tomography (pQCT) data.

Brookes DS, Briody JN, Munns CF, Davies PS, Hill RJ.

J Cyst Fibros. 2015 Sep;14(5):668-77. doi: 10.1016/j.jcf.2015.04.005. Epub 2015 May 6.

41.

The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta.

Biggin A, Zheng L, Briody JN, Coorey CP, Munns CF.

Horm Res Paediatr. 2015;83(3):183-9. doi: 10.1159/000369582. Epub 2015 Feb 10.

PMID:
25676713
42.

Quality of life prediction in children with joint hypermobility syndrome.

Pacey V, Tofts L, Adams RD, Munns CF, Nicholson LL.

J Paediatr Child Health. 2015 Jul;51(7):689-95. doi: 10.1111/jpc.12826. Epub 2015 Jan 26.

PMID:
25622801
43.

Role of the outer pore domain in transient receptor potential vanilloid 1 dynamic permeability to large cations.

Munns CH, Chung MK, Sanchez YE, Amzel LM, Caterina MJ.

J Biol Chem. 2015 Feb 27;290(9):5707-24. doi: 10.1074/jbc.M114.597435. Epub 2015 Jan 7.

44.

Use of bisphosphonates in children: authors' reply.

Bhatt R, Hibbert S, Munns C.

Aust Dent J. 2014 Sep;59(3):405-6. No abstract available.

PMID:
25285345
45.

Proprioceptive acuity into knee hypermobile range in children with joint hypermobility syndrome.

Pacey V, Adams RD, Tofts L, Munns CF, Nicholson LL.

Pediatr Rheumatol Online J. 2014 Sep 8;12:40. doi: 10.1186/1546-0096-12-40. eCollection 2014.

46.

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device.

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M.

EuroIntervention. 2014 Sep;10 Suppl U:U120-8. doi: 10.4244/EIJV10SUA18.

47.

Cystic fibrosis-related bone disease explored using a four step algorithm.

Brookes DS, Briody JN, Munns CF, Davies PS, Hill RJ.

J Cyst Fibros. 2015 Jan;14(1):127-34. doi: 10.1016/j.jcf.2014.07.011. Epub 2014 Aug 29.

48.

Osteogenesis imperfecta: diagnosis and treatment.

Biggin A, Munns CF.

Curr Osteoporos Rep. 2014 Sep;12(3):279-88. doi: 10.1007/s11914-014-0225-0. Review.

PMID:
24964776
49.

Joint hypermobility syndrome subclassification in paediatrics: a factor analytic approach.

Pacey V, Adams RD, Tofts L, Munns CF, Nicholson LL.

Arch Dis Child. 2015 Jan;100(1):8-13. doi: 10.1136/archdischild-2013-305304. Epub 2014 May 26.

PMID:
24861050
50.

Vitamin D supplementation and the effects on glucose metabolism during pregnancy: a randomized controlled trial.

Yap C, Cheung NW, Gunton JE, Athayde N, Munns CF, Duke A, McLean M.

Diabetes Care. 2014 Jul;37(7):1837-44. doi: 10.2337/dc14-0155. Epub 2014 Apr 23. Erratum in: Diabetes Care. 2015 Oct;38(10):1992.

PMID:
24760259

Supplemental Content

Support Center